Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Giles

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2013
The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastomaAmanda Tivnan, Jack Zhao, Terrance G Johns, et al.
Molecular Cancer Therapeutics|September 13, 2013
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinibKeith M Giles, Felicity C Kalinowski, Patrick A Candy, et al.
The Journal of Investigative Dermatology|August 28, 2018
Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in MelanomaKeith M Giles, Brooke E Rosenbaum, Marlies Berger, et al.
Nature|January 4, 2008
Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNADi Yu, Andy Hee-Meng Tan, Xin Hu, et al.
Journal of Translational Medicine|April 3, 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitorsMichael F Gowen, Keith M Giles, Danny Simpson, et al.
The Journal of Biological Chemistry|May 16, 2002
Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3'-untranslated region of the androgen receptor messenger RNABu B Yeap, Dominic C Voon, Julian P Vivian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Identification of a Novel Pathogenic Germline KDR Variant in MelanomaInes P Silva, Amel Salhi, Keith M Giles, et al.
The American Journal of Pathology|January 13, 2015
RSK1 activation promotes invasion in nodular melanomaAmel Salhi, Joshua A Farhadian, Keith M Giles, et al.
Oncotarget|May 21, 2016
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κBKeith M Giles, Rikki A M Brown, Clarissa Ganda, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Oncotarget|September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progressionMichael R Epis, Keith M Giles, Dianne J Beveridge, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2013
The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastomaAmanda Tivnan, Jack Zhao, Terrance G Johns, et al.
Molecular Cancer Therapeutics|September 13, 2013
Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinibKeith M Giles, Felicity C Kalinowski, Patrick A Candy, et al.
The Journal of Investigative Dermatology|August 28, 2018
Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in MelanomaKeith M Giles, Brooke E Rosenbaum, Marlies Berger, et al.
Nature|January 4, 2008
Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNADi Yu, Andy Hee-Meng Tan, Xin Hu, et al.
Journal of Translational Medicine|April 3, 2018
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitorsMichael F Gowen, Keith M Giles, Danny Simpson, et al.
The Journal of Biological Chemistry|May 16, 2002
Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3'-untranslated region of the androgen receptor messenger RNABu B Yeap, Dominic C Voon, Julian P Vivian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Identification of a Novel Pathogenic Germline KDR Variant in MelanomaInes P Silva, Amel Salhi, Keith M Giles, et al.
The American Journal of Pathology|January 13, 2015
RSK1 activation promotes invasion in nodular melanomaAmel Salhi, Joshua A Farhadian, Keith M Giles, et al.
Oncotarget|May 21, 2016
microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κBKeith M Giles, Rikki A M Brown, Clarissa Ganda, et al.
Pageof 4